Literature DB >> 21767209

ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype.

Tristram A P Lett1, Clement C Zai, Arun K Tiwari, Sajid A Shaikh, Olga Likhodi, James L Kennedy, Daniel J Müller.   

Abstract

OBJECTIVES. The ANK3, CACNA1C and ZNF804A genes have been implicated in both bipolar disorders (BPD) and schizophrenia (SCZ). It has been suggested that BPD with psychosis may be a clinical manifestation of genes overlapping between BPD and SCZ. We therefore tested the association of these genes with BPD in a large family-based sample, and then dissected the phenotype into psychosis present or absent subgroups. METHODS. We genotyped four high interest single nucleotide polymorphisms from ANK3 (rs10994336, rs9804190), CACNA1C (rs1006737), and ZNF804A (rs1344706). Family based association testing (FBAT) was performed on 312 families, and within psychotic (N = 158) and non-psychotic BPD (N = 119) subgroups. RESULTS. In the whole sample, we found a nominal association in ZNF804A (rs1344706, P = 0.046), and a trend in CACNA1C (rs1006737, P = 0.077). In the psychotic BPD subgroup, as hypothesized, stronger signals were observed in ZNF804A (P = 0.019) and CACNA1C (P = 0.017). We found no association in the ANK3 markers, but the rs10994336 variant was nominally associated with non-psychotic BPD (P = 0.046). Exploratory analysis revealed the rs1344706 variant was also implicated in suicide-attempt behaviour (P = 0.038). CONCLUSIONS. These tentative results are consistent with the hypothesis that the subphenotype of BPD with psychosis may represent a clinical manifestation of shared genetic liability between BPD and SCZ.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767209     DOI: 10.3109/15622975.2011.564655

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  18 in total

1.  Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Authors:  Chiara Fabbri; Concetta Crisafulli; Raffaella Calati; Diego Albani; Gianluigi Forloni; Marco Calabrò; Rosalba Martines; Siegfried Kasper; Joseph Zohar; Alzbeta Juven-Wetzler; Daniel Souery; Stuart Montgomery; Julien Mendlewicz; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-04       Impact factor: 5.270

2.  Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders.

Authors:  Clement C Zai; Mirko Manchia; Ida Elken Sønderby; Zeynep Yilmaz; Vincenzo De Luca; Arun K Tiwari; Alessio Squassina; Gwyneth C Zai; Sajid A Shaikh; John Strauss; Nicole King; Bernard Le Foll; Allan S Kaplan; Per I Finseth; Arne E Vaaler; Srdjan Djurovic; Ole A Andreassen; John B Vincent; James L Kennedy
Journal:  World J Biol Psychiatry       Date:  2014-09-29       Impact factor: 4.132

3.  Methods for identifying suicide or suicidal ideation in EHRs.

Authors:  K Haerian; H Salmasian; C Friedman
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

Review 4.  Integrative biological analysis for neuropsychopharmacology.

Authors:  Mark R Emmett; Roger A Kroes; Joseph R Moskal; Charles A Conrad; Waldemar Priebe; Fernanda Laezza; Anke Meyer-Baese; Carol L Nilsson
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

Review 5.  An overview of the neurobiology of suicidal behaviors as one meta-system.

Authors:  M Sokolowski; J Wasserman; D Wasserman
Journal:  Mol Psychiatry       Date:  2014-09-02       Impact factor: 15.992

Review 6.  CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease.

Authors:  Shambhu Bhat; David T Dao; Chantelle E Terrillion; Michal Arad; Robert J Smith; Nikolai M Soldatov; Todd D Gould
Journal:  Prog Neurobiol       Date:  2012-06-15       Impact factor: 11.685

Review 7.  CACNA1C: Association With Psychiatric Disorders, Behavior, and Neurogenesis.

Authors:  Anna L Moon; Niels Haan; Lawrence S Wilkinson; Kerrie L Thomas; Jeremy Hall
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

8.  Identification of rare nonsynonymous variants in SYNE1/CPG2 in bipolar affective disorder.

Authors:  Sally Isabel Sharp; Jenny Lange; Radhika Kandaswamy; Mazen Daher; Adebayo Anjorin; Nicholas James Bass; Andrew McQuillin
Journal:  Psychiatr Genet       Date:  2017-06       Impact factor: 2.458

9.  Interaction of the ADRB2 gene polymorphism with childhood trauma in predicting adult symptoms of posttraumatic stress disorder.

Authors:  Israel Liberzon; Anthony P King; Kerry J Ressler; Lynn M Almli; Peng Zhang; Sean T Ma; Gregory H Cohen; Marijo B Tamburrino; Joseph R Calabrese; Sandro Galea
Journal:  JAMA Psychiatry       Date:  2014-10       Impact factor: 21.596

10.  Glutamatergic and HPA-axis pathway genes in bipolar disorder comorbid with alcohol- and substance use disorders.

Authors:  Shareefa Dalvie; Chiara Fabbri; Raj Ramesar; Alessandro Serretti; Dan J Stein
Journal:  Metab Brain Dis       Date:  2015-11-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.